authors
- Cooper, Lisa
- Frain, Laura N
- Wee, Jon O
- Dezube, Aaron R
- De León, Luis E
- Kucukak, Suden
- Mazzola, Emanuele
- Dumontier, Clark
- Mamon, Harvey
- Enzinger, Peter
- Jaklitsch, Michael T
Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2021
published in
has subject area
- Adenocarcinoma
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- Carboplatin
- Carcinoma, Squamous Cell
- Chemoradiotherapy, Adjuvant
- Esophageal Neoplasms
- Esophagectomy
- Female
- Humans
- Length of Stay
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Paclitaxel
- Patient Compliance
- Postoperative Complications
- Radiotherapy Dosage
- Retrospective Studies
- Survival Rate
- Time Factors